| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$733,708 ) |
| | 2023 | 2022 | CARDIALEN INC | 6160 SUMMIT DR N | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 002 | 5 | NIH | 9/6/2023 | $0 |
| | 2023 | 2022 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 5 | NIH | 10/28/2022 | $0 |
| | 2023 | 2021 | CARDIALEN INC | 6160 SUMMIT DR N | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 002 | 2 | NIH | 9/6/2023 | -$650,906 |
| | 2023 | 2021 | CARDIALEN INC | 6160 SUMMIT DR N | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 001 | 2 | NIH | 8/31/2023 | $0 |
| | 2023 | 2021 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 000 | 2 | NIH | 10/28/2022 | $0 |
| | 2023 | 2018 | CARDIALEN INC | 6160 SUMMIT DR N | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 001 | 3 | NIH | 3/14/2023 | -$82,802 |
|
| Issue Date FY: 2022 ( Subtotal = $999,810 ) |
| | 2022 | 2022 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 001 | 5 | NIH | 8/3/2022 | $999,810 |
| | 2022 | 2021 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 000 | 2 | NIH | 3/15/2022 | $0 |
| | 2022 | 2018 | CARDIALEN INC | 6160 SUMMIT DR N | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 3 | NIH | 10/30/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,177,310 ) |
| | 2021 | 2021 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 4 | NIH | 6/30/2021 | $999,374 |
| | 2021 | 2021 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 001 | 2 | NIH | 8/22/2021 | $1,177,936 |
| | 2021 | 2020 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 000 | 1 | NIH | 8/20/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,605,396 ) |
| | 2020 | 2020 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL154937 | Novel Therapy System for Atrial Fibrillation | 000 | 1 | NIH | 9/2/2020 | $1,605,396 |
| | 2020 | 2018 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 3 | NIH | 6/20/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2018 | CARDIALEN, INC. | 4041 FOREST PARK AVE | SAINT LOUIS | MO | 63108-3213 | SAINT LOUIS CITY | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 001 | 3 | NIH | 1/10/2019 | $0 |
| | 2019 | 2018 | CARDIALEN, INC. | 6160 SUMMIT DR N STE 450 | MINNEAPOLIS | MN | 55430-2121 | HENNEPIN | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 002 | 3 | NIH | 4/1/2019 | $0 |
| | 2019 | 2017 | CARDIALEN, INC. | 4041 FOREST PARK AVE | SAINT LOUIS | MO | 63108-3213 | SAINT LOUIS CITY | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 2 | NIH | 1/9/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $641,076 ) |
| | 2018 | 2018 | CARDIALEN, INC. | 4041 FOREST PARK AVE | SAINT LOUIS | MO | 63108-3213 | SAINT LOUIS CITY | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 3 | NIH | 8/6/2018 | $641,076 |
|
| Issue Date FY: 2017 ( Subtotal = $1,351,728 ) |
| | 2017 | 2017 | CARDIALEN, INC. | 4041 FOREST PARK AVE | SAINT LOUIS | MO | 63108-3213 | SAINT LOUIS CITY | USA | R44HL107055 | Implantable Unpinning Termination Therapy for Cardiac Arrhythmias | 000 | 2 | NIH | 6/12/2017 | $1,351,728 |
|
| Issue Date FY: 2014 ( Subtotal = $0 ) |
| | 2014 | 2012 | CARDIALEN INC | 4041 FOREST PARK AVENUE | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R41HL114329 | Low energy ventricular defibrillator | 000 | 1 | NIH | 8/14/2014 | $0 |
|
| Issue Date FY: 2012 ( Subtotal = $250,742 ) |
| | 2012 | 2012 | CARDIALEN INC | 4041 FOREST PARK AVENUE | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R41HL114329 | Low energy ventricular defibrillator | 000 | 1 | NIH | 8/3/2012 | $250,742 |
|
| Issue Date FY: 2011 ( Subtotal = $216,027 ) |
| | 2011 | 2011 | CARDIALEN INC | 4041 FOREST PARK AVENUE | SAINT LOUIS | MO | 63108 | SAINT LOUIS CITY | USA | R43HL107055 | ENHANCED SYSTEM FOR ATRIAL DEFIBRILLATION | 000 | 1 | NIH | 2/14/2011 | $216,027 |
|
|
